Hongzhen Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hongzhen Qin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Anheng Liu
307 Hospital of PLA
1 shared publication- Jiahong Liu
State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China Institute of Water Resources and Hydropower Research, Beijing 100038, China
1 shared publication Jing Fu
Beijing Institute of Biotechnology
1 shared publicationJuqiang Han
Beijing Military General Hospital
1 shared publication- Lei Kang
Department of Nuclear Medicine, Peking University First Hospital, Beijing, China
1 shared publication - Qinong Ye
National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
1 shared publication
Latest Publications
- 15 November 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (4) , 3526-3537
MicroRNA‐99a‐5p suppresses breast cancer progression and cell‐cycle pathway through downregulating CDC25A
In this study, we aimed to explore the association between miR‐99a‐5p and CDC25A in breast cancer and the regulatory mechanisms of miR‐99a‐5p on breast cancer. The expressions of messenger RNA and microRNAs in breast cancer tissues and adjacent tissues were analyzed by the Cancer Genome Atlas microarray analysis. Quantitative real‐time polymerase chain reaction was conducted to find out the expression levels of miR‐99a‐5p and CDC25A. The expression levels of proteins (CDC25A, ki67, cyclin D1, p21, BAX, BCL‐2, BCL‐XL, MMP2, and MMP9) were determined by Western blot analysis. The relationship between miR‐99a‐5p and CDC25A was predicted and verified by bioinformatics analysis and dual luciferase assay. After transfection, cell proliferation, invasion, and apoptosis of breast cancer tissues were, respectively, observed by cell counting kit‐8 assay, transwell assay, and flow cytometry (FCM). Furthermore, the relationship among miR‐99a‐5p, CDC25A, and cell‐cycle progression was determined by FCM assay. The nude mouse transplantation tumor experiment was performed to verify the influence of miR‐99a‐5p on breast cancer cell in vivo. The expression of miR‐99a‐5p in breast cancer tissues and cells was significantly downregulated, whereas CDC25A expression was upregulated. MiR‐99a‐5p targeted CDC25A and suppressed its expression in breast cancer cells. Overexpression of miR‐99a‐5p and decreased expression of CDC25A could suppress breast cancer cell proliferation and invasion and facilitate apoptosis. Cell‐cycle progression was significantly activated by downregulated miR‐99a‐5p and upregulated CDC25A. Moreover, miR‐99a‐5p overexpression repressed the expressions of CDC25A, marker ki67, and Cyclin D1 proteins, whereas it upregulated the expression of p21 protein. MicroRNA‐99a‐5p suppresses breast cancer progression and cell‐cycle pathway through downregulating CDC25A.
- 15 November 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (4) , 3526-3537
MicroRNA‐99a‐5p suppresses breast cancer progression and cell‐cycle pathway through downregulating CDC25A
In this study, we aimed to explore the association between miR‐99a‐5p and CDC25A in breast cancer and the regulatory mechanisms of miR‐99a‐5p on breast cancer. The expressions of messenger RNA and microRNAs in breast cancer tissues and adjacent tissues were analyzed by the Cancer Genome Atlas microarray analysis. Quantitative real‐time polymerase chain reaction was conducted to find out the expression levels of miR‐99a‐5p and CDC25A. The expression levels of proteins (CDC25A, ki67, cyclin D1, p21, BAX, BCL‐2, BCL‐XL, MMP2, and MMP9) were determined by Western blot analysis. The relationship between miR‐99a‐5p and CDC25A was predicted and verified by bioinformatics analysis and dual luciferase assay. After transfection, cell proliferation, invasion, and apoptosis of breast cancer tissues were, respectively, observed by cell counting kit‐8 assay, transwell assay, and flow cytometry (FCM). Furthermore, the relationship among miR‐99a‐5p, CDC25A, and cell‐cycle progression was determined by FCM assay. The nude mouse transplantation tumor experiment was performed to verify the influence of miR‐99a‐5p on breast cancer cell in vivo. The expression of miR‐99a‐5p in breast cancer tissues and cells was significantly downregulated, whereas CDC25A expression was upregulated. MiR‐99a‐5p targeted CDC25A and suppressed its expression in breast cancer cells. Overexpression of miR‐99a‐5p and decreased expression of CDC25A could suppress breast cancer cell proliferation and invasion and facilitate apoptosis. Cell‐cycle progression was significantly activated by downregulated miR‐99a‐5p and upregulated CDC25A. Moreover, miR‐99a‐5p overexpression repressed the expressions of CDC25A, marker ki67, and Cyclin D1 proteins, whereas it upregulated the expression of p21 protein. MicroRNA‐99a‐5p suppresses breast cancer progression and cell‐cycle pathway through downregulating CDC25A.
- 2 March 2013
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 378 (1-2) , 161-169
The molecular mechanism and potential role of heat shock-induced p53 protein accumulation
Workers who are exposed to extreme heat or work in hot environments may be at risk of heat stress. Exposure to extreme heat can result in occupational illnesses and injuries. On the other hand, local and regional heat therapy has been used for the treatment of some cancers, such as liver cancer, lung cancer, and kidney cancer. Although heat stress has been shown to induce the accumulation of p53 protein, a key regulator of cell cycle, apoptosis, DNA repair, and autophagy, how it regulates p53 protein accumulation and what the p53 targets are remain unclear. Here, we show that, among various genotoxic stresses, including ionizing radiation (IR) and ultraviolet (UV) radiation, heat stress contributes significantly to increase p53 protein levels in normal liver cells and liver cancer cells. Heat stress did not increase p53 mRNA expression as well as p53 promoter activity. However, heat stress enhanced the half-life of p53 protein. Moreover, heat stress increased the expression of puma and light chain 3 (LC-3), which are associated with the apoptotic and autophagic function of p53, respectively, whereas it did not change the expression of the cell cycle regulators p21, 14-3-3δ, and GADD45α, suggesting that heat-triggered alteration of p53 selectively modulates the downstream targets of p53. Our study provides a novel mechanism by which heat shock stimulates p53 protein accumulation, which is different from common DNA damages, such as IR and UV, and also provides new molecular basis for heat injuries or heat therapy.
- 2 March 2013
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 378 (1-2) , 161-169
The molecular mechanism and potential role of heat shock-induced p53 protein accumulation
Workers who are exposed to extreme heat or work in hot environments may be at risk of heat stress. Exposure to extreme heat can result in occupational illnesses and injuries. On the other hand, local and regional heat therapy has been used for the treatment of some cancers, such as liver cancer, lung cancer, and kidney cancer. Although heat stress has been shown to induce the accumulation of p53 protein, a key regulator of cell cycle, apoptosis, DNA repair, and autophagy, how it regulates p53 protein accumulation and what the p53 targets are remain unclear. Here, we show that, among various genotoxic stresses, including ionizing radiation (IR) and ultraviolet (UV) radiation, heat stress contributes significantly to increase p53 protein levels in normal liver cells and liver cancer cells. Heat stress did not increase p53 mRNA expression as well as p53 promoter activity. However, heat stress enhanced the half-life of p53 protein. Moreover, heat stress increased the expression of puma and light chain 3 (LC-3), which are associated with the apoptotic and autophagic function of p53, respectively, whereas it did not change the expression of the cell cycle regulators p21, 14-3-3δ, and GADD45α, suggesting that heat-triggered alteration of p53 selectively modulates the downstream targets of p53. Our study provides a novel mechanism by which heat shock stimulates p53 protein accumulation, which is different from common DNA damages, such as IR and UV, and also provides new molecular basis for heat injuries or heat therapy.